tiprankstipranks
Protalix Biotherapeutics (PLX)
:PLX
US Market
PLX
Protalix
RESEARCH TOOLSreports
Want to see PLX full AI Analyst Report?

Protalix (PLX) Ownership - Who Owns Protalix?

948 Followers

Protalix (PLX) Ownership Overview

3.87%2.66%0.61%4.25%88.61%
3.87% Insiders
2.66% Mutual Funds
0.61% Other Institutional Investors
4.25% ETFs
88.61% Public Companies and
Individual Investors
The ownership structure of Protalix (PLX) stock is a mix of institutional, retail, and individual investors. Approximately 7.52% of the company’s stock is owned by Institutional Investors, 3.87% is owned by Insiders, and 88.61% is owned by Public Companies and Individual Investors.
The ownership structure of Protalix (PLX) stock is a mix of institutional, retail, and individual investors. Approximately 3.27% of the company’s stock is owned by Institutional Investors, 3.87% is owned by Insiders, and 4.25% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 23, 2025
Dror Bashan
xxxxxxxxxxxxx
$101360
Nov 19, 2025
Amos Bar Shalev
xxxxxxxxxxxxx
$314
Aug 12, 2025
Aharon Schwartz
xxxxxxxxxxxxx
$205110
Show More Insider Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,532,934Insider3.14%5,369,820
2,414,111Institution3.00%5,117,915
749,835Institution0.93%1,589,650
432,485Institution0.54%916,868
427,642Institution0.53%906,601
341,207Institution0.42%723,359
310,500Insider0.39%658,260
279,934Institution0.35%593,460
232,929Insider0.29%493,809
180,000Institution0.22%381,600

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
749,835Institution0.93%1,589,650
427,642Institution0.53%906,601
341,207Institution0.42%723,359
180,000Institution0.22%381,600
175,070Institution0.22%371,148
74,338Institution0.09%157,597
33,278Institution0.04%70,549
29,103Institution0.04%61,698
23,784Institution0.03%50,422
19,300Institution0.02%40,916

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
iShares Russell 2000 ETF
1,613,837Institution2.00%3,421,334
iShares Russell 2000 Growth ETF
615,138Institution0.76%1,304,093
Vanguard Russell 2000 ETF
360,580Institution0.45%782,459
Dimensional U.S. Small Cap ETF
262,598Institution0.33%564,586
iShares Micro-Cap ETF
185,136Institution0.23%398,042
WisdomTree U.S. SmallCap Fund
79,350Institution0.10%168,222
Vanguard Russell 2000 Growth ETF
66,380Institution0.08%144,045
Global X Russell 2000 ETF
31,470Institution0.04%66,716
Dimensional U.S. Core Equity 2 ETF
10,251Institution0.01%22,040
Dimensional US Sustainability Core 1 ETF
7,085Institution<0.01%15,020

FAQ

Who Owns Protalix Biotherapeutics (PLX)?
According to the latest TipRanks data, approximately 0.61% of the company's stock is held by institutional investors, 3.87% is held by insiders, and 88.61% is held by retail investors.
    What percentage of Protalix Biotherapeutics (PLX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.61% of Protalix Biotherapeutics (PLX) stock is held by institutional investors.
      What percentage of Protalix Biotherapeutics (PLX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 88.61% of Protalix Biotherapeutics (PLX) stock is held by retail investors.
        Who owns the most shares of Protalix Biotherapeutics (PLX)?
        Dror Bashan owns the most shares of Protalix Biotherapeutics (PLX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.